Your browser doesn't support javascript.
loading
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myeloma.
Vasudevan Nampoothiri, Ram; Pasic, Ivan; Law, Arjun Datt; Lam, Wilson; Chen, Carol; Michelis, Fotios V; Kim, Dennis Dong Hwan; Gerbitz, Armin; Lipton, Jeffrey Howard; Kumar, Rajat; Mattsson, Jonas; Viswabandya, Auro.
Afiliação
  • Vasudevan Nampoothiri R; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Pasic I; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Law AD; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Lam W; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Chen C; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Gerbitz A; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Kumar R; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Mattsson J; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
  • Viswabandya A; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
Eur J Haematol ; 108(5): 430-436, 2022 May.
Article em En | MEDLINE | ID: mdl-35100661
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Segunda Neoplasia Primária / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Doença Enxerto-Hospedeiro / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Segunda Neoplasia Primária / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Doença Enxerto-Hospedeiro / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá